7498 Results (Page 284 of 300)
Pharmaceuticals Markets Research Reports
UAE Chronic Pain Therapeutics Market Analysis
The UAE Chronic Pain Therapeutics Market is anticipated to experience a growth from $372 Mn in 2022 to $634 Mn by 2030, with a CAGR of 6.9% during the forecast period of 2022-2030. The key drivers include the growing elderly population's susceptibility to age-related conditions, a shifting attitude toward pain management, and an increased demand for non-opioid alternatives amid concerns about opioid addiction and side effects. The UAE Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sanofi, Merck & Co., Tabuk Pharmaceuticals, Pharmed, Julphur Pharmaceuticals, etc., among various others.
China Dental Fluoride Treatment Market Analysis
The China Dental Fluoride Treatment Market was valued at $1219.2 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $1761.9 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Colgate, Amway (China) Co. Ltd, Colgate-Palmolive Co, GlaxoSmithKline plc, Guangxi Aoqili Co. Ltd among others.
UK Chronic Pain Therapeutics Market Analysis
The UK Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.932 Bn in 2022 to $2.624 Bn by 2030, with a CAGR of 3.9% during the forecast period of 2022-2030. The main drivers of market growth include the imperative for cost-effective medicines to address the substantial financial burden on the NHS, rising demand for non-opioid treatments due to concerns over opioid risks, and the increasing prevalence of chronic pain linked to an aging population and the growing incidence of chronic diseases. The UK Chronic Pain Therapeutics Market encompasses various players across different segments, including Sanofi, Pfizer, Merck, Novartis, Bayer, Amgen, Abbott, AstraZeneca, Norgine, Xenova, etc., among various others.
Indonesia Dental Fluoride Treatment Market Analysis
The Indonesia Dental Fluoride Treatment Market was valued at $91 Mn in 2023 and is projected to grow at a CAGR of 3.9% from 2023 to 2023, to $119 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment and to advance a holistic method of oral health equity has contributed to market growth. The industry is primarily dominated by players such as Lion wings, Unilever Indonesia, Mitra Natura Raya, Colgate, GSK and Procter & Gamble among others.
US Chronic Pain Therapeutics Market Analysis
The US Chronic Pain Therapeutics Market is anticipated to experience a growth from $31.206 Bn in 2022 to $42.380 Bn by 2030, with a CAGR of 3.9% during the forecast period of 2022-2030. The combination of an aging population, high unmet needs, and the shift towards non-opioid options is reshaping the landscape of chronic pain therapeutics in the US. The US Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Merck, Pfizer, Sanofi, Amgen, Biogen, Teva Pharmaceuticals, etc., among various others.
Japan Dental Fluoride Treatment Market Analysis
The Japan Dental Fluoride Treatment Market was valued at $942.8 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $1,274.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Lion Corporation, Sunstar Group, Kao Corporation, GlaxoSmithKline, and Procter & Gamble among others.
Brazil Cold Pain Therapy Market Analysis
The Brazil Cold Pain Therapy Market was valued at $55 Mn in 2022 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $89 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, demand for non-pharmaceutical alternatives in the industry, and focus on sports medicine and rehabilitation. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Sanofi, Ossur, Rohto, Pfizer, and Cardinal Health among others.
Malaysia Dental Fluoride Treatment Market Analysis
The Malaysia Dental Fluoride Treatment Market was valued at $24.4 Mn in 2023 and is projected to grow at a CAGR of 4.1% from 2023 to 2023, to $32.3 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Colgate-Palmolive, Sarjana Sumber, Southern Lion, Tohtohku, Kotra Pharma and Hovid Berhad among others.
Philippines Dental Fluoride Treatment Market Analysis
The Philippines Dental Fluoride Treatment Market was valued at $33.4 Mn in 2023 and is projected to grow at a CAGR of 4.4% from 2023 to 2023, to $45.1 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. Furthermore, increasing support from the government to improve access to person-cantered treatment contributed to market growth. The industry is primarily dominated by players such as Lamoiyan Corporation, Colgate, Splash Corporation, Dentsply Sirona, VOCO, among others.
China Cold Pain Therapy Market Analysis
The China Cold Pain Therapy Market was valued at $177 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $297 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic pain disorders, technological advances in the industry, and changing consumer preferences. The industry is primarily dominated by players such as Meditech, Beijing Beike, Ossur, Shanghai Olympus, Pfizer, and Hisamitsu among others.
Singapore Dental Fluoride Treatment Market Analysis
The Singapore Dental Fluoride Treatment Market was valued at $18.2 Mn in 2023 and is projected to grow at a CAGR of 4.5% from 2023 to 2023, to $24.8 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Pearlie White, Zenyum, Pigeon Singapore, Unilever, P & G among others
Egypt Cold Pain Therapy Market Analysis
The Egypt Cold Pain Therapy Market was valued at $6 Mn in 2022 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $10 Mn by 2030. The key drivers of this industry include the rising burden of chronic pain disorders, expanded product offerings, and supportive government initiatives. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
Vietnam Dental Fluoride Treatment Market Analysis
The Vietnam Dental Fluoride Treatment Market was valued at $75.8 Mn in 2023 and is projected to grow at a CAGR of 4.13% from 2023 to 2023, to $100.7 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as are Colgate Palmolive, GSK, Unilever, P&G, Sanofi among others.
France Cold Pain Therapy Market Analysis
The France Cold Pain Therapy Market was valued at $61 Mn in 2022 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $84 Mn by 2030. The key drivers of this industry include the increasing prevalence of pain disorders, technological advances in the industry, and supportive government initiatives. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Custom Ice, Ossur, Medline, Pfizer, and Performance Health among others.
Canada Periodontal Therapeutics Market Analysis
The Canada Periodontal Therapeutics Market was valued at $69.8 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $113.6 Mn by 2030. Canada Periodontal Therapeutics Market is growing due to Prevalence of periodontitis, Rise in Demand for Non-surgical Periodontal Therapies, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Germany Cold Pain Therapy Market Analysis
The Germany Cold Pain Therapy Market was valued at $81 Mn in 2022 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $105 Mn by 2030. The key drivers of this industry include a surge in the prevalence of pain disorders, technological advances in the industry, and increasing product innovation. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Beiersdorf, Ossur, Medline, Pfizer, and Cardinal Health among others.
US Periodontal Therapeutics Market Analysis
The US Periodontal Therapeutics Market was valued at $366.6 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $522.7 Mn by 2030. The US Periodontal Therapeutics Market is growing due to Rise in prevalence of periodontitis, Emphasis on Preventive Oral Care, and Technological Developments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Egypt Dental Fluoride Treatment Market Analysis
The Egypt Dental Fluoride Treatment Market was valued at $42.5 Mn in 2023 and is projected to grow at a CAGR of 5.4% from 2023 to 2023, to $61.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Sigma Pharmaceuticals Industries, Arab Drug Company, MACRO Group, Pharco Pharmaceuticals and Hindustan Unilever Limited among others.
Indonesia Cold Pain Therapy Market Analysis
The Indonesia Cold Pain Therapy Market was valued at $13 Mn in 2022 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $20 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic pain disorders, expanding product offerings, and growing government investments. The industry is primarily dominated by players such as Kalbe Pharma, Medline, Novell, Ossur, Romsons, Pfizer, and Hisamitsu among others.
Saudi Arabia Periodontal Therapeutics Market Analysis
The Saudi Arabia Periodontal Therapeutics Market was valued at $14.8 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $26.6 Mn by 2030. Saudi Arabia Periodontal Therapeutics Market is growing due to Rising Awareness About Dental Hygiene, Prevalence of periodontitis, and Advancements in Treatment Technologies. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Kenya Dental Fluoride Treatment Market Analysis
The Kenya Dental Fluoride Treatment Market was valued at $10.6 Mn in 2023 and is projected to grow at a CAGR of 5% from 2023 to 2023, to $14.9 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Beta Healthcare International, Harleys Limited, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
UAE Periodontal Therapeutics Market Analysis
The UAE Periodontal Therapeutics Market was valued at $4.4 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $7.6 Mn by 2030. UAE Periodontal Therapeutics Market is growing due to Rising Geriatric Population, Government Support and Initiative and Advancements in Treatment Technologies. The market is primarily dominated by players such as 3M Company UAE, Zimmer Biomet UAE, Dentsply Sirona UAE, Planmeca UAE, Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd and Bausch Health Companies Inc.
South Africa Dental Fluoride Treatment Market Analysis
The South Africa Dental Fluoride Treatment Market was valued at $98.6 Mn in 2023 and is projected to grow at a CAGR of 5.13% from 2023 to 2023, to $139.9 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Clicks Group, Tiger Brands, Ivodent, Dis-Chem, CIPLA Medpro among others.
Kenya Cold Pain Therapy Market Analysis
The Kenya Cold Pain Therapy Market was valued at $2 Mn in 2022 and is predicted to grow at a CAGR of 6.3% from 2023 to 2030, to $3 Mn by 2030. The key drivers of this industry include the rising burden of chronic pain disorders, growing demand for non-pharmaceutical approaches, and increasing government investments. The industry is primarily dominated by players such as Ossur, Rohto, Pfizer, Hisamitsu, Johnson & Johnson, Sanofi, and Breg among others.
Brazil Periodontal Therapeutics Market Analysis
The Brazil Periodontal Therapeutics Market was valued at $21.8 Mn in 2023 and is predicted to grow at a CAGR of 8.2% from 2023 to 2030, to $37.9 Mn by 2030. Brazil Periodontal Therapeutics Market is growing due to Rising Prevalence of periodontitis, Technological Advancements, and Emphasis on Preventive Oral Care. The market is primarily dominated by players such as Tokyo Chemical Industry Co. Ltd., Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, and Bausch Health Companies Inc.
